The 4100 Group

Venture Capital Firm

The 4100 Group
MVCA Member

4100DX stands at the forefront of health innovation and patient capital, uniquely merging long-term investment with transformative healthcare advancements.

Contact

Team

  • Scott McLean
    Managing Director, The 4100 Group
  • Scott Lancaster, MD
    Managing Director, The 4100 Group
  • Mariya Filipova
    The 4100 Group

Stages of Investment

  • Startup/Early

Sectors of Investment

  • Other

IT Subsectors

  • Not Applicable

Life Science Subsectors

  • Not Applicable

Details

  • Assets Under Management $25,000,000
  • Funds Managed (Current & Historical)3
  • Actively InvestingYes

The most timely & relevant email you will get about Michigan’s investment & entrepreneurial ecosystem.

From public policy to the new ideas and breakthrough investment opportunities, MVCA will keep your finger on the pulse of must know information in the industry.

Newsletter

This field is for validation purposes and should be left unchanged.